Insurance Approval for Definitive Proton Therapy for Prostate Cancer

Insurance Approval for Definitive Proton Therapy for Prostate Cancer

Purpose: To determine factors that influence insurance approval for definitive proton therapy (PT) for prostate cancer. Materials and Methods: Between 2014 and 2018, 1592 insured patients with localized prostate cancer were evaluated and recommended to undergo definitive PT; 547 patients (34.4%) had...

Full description

Bibliographic Details
Main Authors: Brooks, E.D (Author), Bryant, C.B (Author), Henderson, R.H (Author), Klein, S.L (Author), McIntyre, K. (Author), Mendenhall, N.P (Author), Mendenhall, W.M (Author), Morris, C.G (Author), Nichols, R.C., Jr (Author), Smith, S. (Author)
Format: Article
Language:English
Published: Allen Press Inc. 2022
Subjects:
insurance
prostate cancer
proton therapy
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items